Recently, relevant national authorities jointly released the ‘White Paper on AI Healthcare Governance,’ aiming to regulate the application of artificial intelligence in the healthcare sector and promote its safe, reliable, and controllable development. The white paper systematically reviews the current state of AI in healthcare, its application scenarios, and potential risks, proposing core governance principles centered on ‘human-centricity, safety and controllability, fairness and transparency, and clear accountability.’ It emphasizes that AI-driven medical products and services must undergo rigorous ethical review and clinical validation to ensure patient privacy and data security. Additionally, the white paper calls for establishing cross-departmental collaborative oversight mechanisms, improving standardization frameworks, and deepening integration among industry, academia, research, and clinical practice. This move marks a significant step toward institutionalizing and standardizing AI healthcare governance in China, offering a Chinese approach to the global advancement of responsible AI in healthcare.
近日，国家相关部门联合发布《AI医疗治理白皮书》，旨在规范人工智能在医疗健康领域的应用，推动技术安全、可靠、可控发展。该白皮书系统梳理了当前AI医疗的发展现状、应用场景与潜在风险，并提出以‘以人为本、安全可控、公平透明、责任明确’为核心的治理原则。文件强调，AI医疗产品和服务必须通过严格的伦理审查与临床验证，确保患者隐私保护和数据安全。同时，白皮书呼吁建立跨部门协同监管机制，完善标准体系，促进产学研用深度融合。此举标志着我国在AI医疗治理领域迈出制度化、规范化的重要一步，为全球AI医疗健康发展提供中国方案。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/13572.html